ENVX vs. CRSP

Last updated Apr 2, 2026

Compare and contrast key facts about Enovix Corp (ENVX) and CRISPR Therapeutics AG (CRSP).

Performance

ENVX vs. CRSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enovix Corp (ENVX) and CRISPR Therapeutics AG (CRSP). The values are adjusted to include any dividend payments, if applicable.

ENVX vs. CRSP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ENVX Enovix Corp	-32.01%	-23.14%	-13.18%	0.64%	-54.40%	53.86%
CRSP CRISPR Therapeutics AG	-6.92%	33.23%	-37.12%	54.00%	-46.36%	-40.38%

Fundamentals

EPS ENVX : -$759.32 CRSP : -$5.47
PS Ratio ENVX : 0.03 CRSP : 118.44
Total Revenue (TTM) ENVX : $31.82B CRSP : $36.75M
Gross Profit (TTM) ENVX : $6.11B CRSP : -$130.60M
EBITDA (TTM) ENVX : -$177.20B CRSP : -$529.50M

Returns By Period

In the year-to-date period, ENVX achieves a -32.01% return, which is significantly lower than CRSP's -6.92% return.

ENVX

• 1D: -4.05%
• 1M: -8.81%
• YTD: -32.01%
• 6M: -55.27%
• 1Y: -23.66%
• 3Y*: -27.51%
• 5Y*: —
• 10Y*: —

CRSP

• 1D: 2.61%
• 1M: -19.68%
• YTD: -6.92%
• 6M: -26.22%
• 1Y: 47.28%
• 3Y*: 2.57%
• 5Y*: -16.38%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ENVX vs. CRSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENVX

ENVX Risk / Return Rank: 31
ENVX Sharpe Ratio Rank: 28
ENVX Sortino Ratio Rank: 33
ENVX Omega Ratio Rank: 33
ENVX Calmar Ratio Rank: 31
ENVX Martin Ratio Rank: 32

CRSP

CRSP Risk / Return Rank: 64
CRSP Sharpe Ratio Rank: 66
CRSP Sortino Ratio Rank: 67
CRSP Omega Ratio Rank: 62
CRSP Calmar Ratio Rank: 63
CRSP Martin Ratio Rank: 60

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENVX vs. CRSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enovix Corp (ENVX) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ENVX	CRSP	Difference
Sharpe ratio Return per unit of total volatility	-0.27	0.75	-1.01
Sortino ratio Return per unit of downside risk	0.20	1.50	-1.30
Omega ratio Gain probability vs. loss probability	1.02	1.17	-0.15
Calmar ratio Return relative to maximum drawdown	-0.32	1.03	-1.35
Martin ratio Return relative to average drawdown	-0.56	2.03	-2.59
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ENVX vs. CRSP - Sharpe Ratio Comparison

The current ENVX Sharpe Ratio is -0.27, which is lower than the CRSP Sharpe Ratio of 0.75. The chart below compares the historical Sharpe Ratios of ENVX and CRSP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ENVX	CRSP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.27	0.75	-1.01
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.27	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.23	0.22	-0.45

Correlation

The correlation between ENVX and CRSP is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

ENVX vs. CRSP - Dividend Comparison

Neither ENVX nor CRSP has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ENVX vs. CRSP - Drawdown Comparison

The maximum ENVX drawdown since its inception was -84.76%, roughly equal to the maximum CRSP drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for ENVX and CRSP.

Drawdown Indicators

	ENVX	CRSP	Difference
Max Drawdown Largest peak-to-trough decline	-84.76%	-85.11%	+0.35%
Max Drawdown (1Y) Largest decline over 1 year	-69.62%	-42.25%	-27.37%
Max Drawdown (5Y) Largest decline over 5 years	—	-80.68%	—
Current Drawdown Current decline from peak	-84.14%	-76.76%	-7.38%
Average Drawdown Average peak-to-trough decline	-61.93%	-48.71%	-13.22%
Ulcer Index Depth and duration of drawdowns from previous peaks	40.38%	21.35%	+19.03%

Volatility

ENVX vs. CRSP - Volatility Comparison

Enovix Corp (ENVX) and CRISPR Therapeutics AG (CRSP) have volatilities of 18.42% and 18.14%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ENVX	CRSP	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.42%	18.14%	+0.28%
Volatility (6M) Calculated over the trailing 6-month period	61.12%	44.91%	+16.21%
Volatility (1Y) Calculated over the trailing 1-year period	88.56%	63.81%	+24.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	93.67%	60.36%	+33.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	93.67%	64.42%	+29.25%

Financials